Psoriasis. Student's Name. Institution. Date of Submission



Similar documents
X-Plain Psoriasis Reference Summary

Psoriasis. Psoriasis. Mark A. Bechtel, M.D. Director of Dermatology The Ohio State University College of Medicine

What is Psoriasis? Common Areas Affected. Type Who Does it Affect Characteristics

FastTest. You ve read the book now test yourself

Psoriasis Can be Cured with Homoeopathy

Is Monotherapy Treatment of Etanercept Effective Against Plaque Psoriasis?

Psoriasis Treatment Transition Pathway

Phenotypes and Classification of Psoriasis

PSORIASIS AND ITS. Learn how vitamin D medications play an important role in managing plaque psoriasis

Skin cancer Patient information

PSORIATIC ARTHRITIS. Chryssanthie Kafkala, M.D. INTRODUCTION:

Psoriatic arthritis FACTSHEET

TREATMENTS FOR MODERATE OR SEVERE PSORIASIS

Psoriasis. Background

Nail Psoriasis. A positive approach. to psoriasis and. psoriatic arthritis

Treatment options a simple guide

TOPICAL TREATMENTS FOR PSORIASIS

GENETIC ANALYSIS OF PSORIASIS AND PSORIATIC ARTHRITIS Department of Dermatology, University of Michigan

Leukocytoclastic Vasculitis and Stasis Dermatitis With Id Reaction

Once the immune system is triggered, cells migrate from the blood into the joints and produce substances that cause inflammation.

Course: Acupuncture Treatment of Disease 3 Date: June 22, 2009 Class #: 10 Psoriasis, Fibromyalgia/CFS. Psoriasis

PRACTICAL HELP FROM THE ARTHRITIS FOUNDATION Psoriatic Arthritis

Psoriasis is a skin condition that causes scaly red patches on your skin. There's no cure for psoriasis, but there are treatments that can help.

Treating psoriasis and psoriatic arthritis. A booklet for patients and carers

SQUAMOUS CELL CARCINOMA

Psoriatic Arthritis

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis

Rheumatoid Arthritis

More details >>> HERE <<<

Additional details >>> HERE <<<

Biologic Treatments for Rheumatoid Arthritis

Jerry Bagel, MD of Windsor Dermatology Home of the Psoriasis Treatment Center of Central New Jersey

(Intro to Arthritis with a. Arthritis) Manager of Education & Services for the Vancouver Island Region of The Arthritis Society

ARTHRITIS INTRODUCTION

How To Treat Psoriasis With Omega 3 Fatty Acids

Preetha selva et al. / International Journal of Phytopharmacology. 6(1), 2015, International Journal of Phytopharmacology

VITILIGO Charles Camisa, MD 1/24/12. Vitiligo is a common autoimmune skin disease that causes gradual loss of the natural

Rheumatoid Arthritis: Symptoms, Causes, and Treatments of Rheumatoid Foot and Ankle

National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL or FAX nmic@stjames.

Rheumatoid Arthritis

A Genetic Analysis of Rheumatoid Arthritis

Additional information >>> HERE <<< How To scalp psoriasis treatment philippines Scam or Work?

HLA-Cw*0602 associates with a twofold higher prevalence. of positive streptococcal throat swab at the onset of

Arthritis in Children: Juvenile Rheumatoid Arthritis By Kerry V. Cooke

Smoothbeam Laser Treatment of Acne Vulgaris. Emerging Applications

Psoriasis: Controlled YOUR GUIDE TO BIOLOGICAL TREATMENTS FOR PLAQUE PSORIASIS

PowerLight LED Light Therapy. The FUTURE of corrective skin

Graft-versus-host disease (GvHD)

Psoriasis and lichen planus. Department of Dermatology SRM MCH & RC

Treating your skin condition with narrowband ultraviolet B radiation (NB-UVB)

21 st CENTURY(December 23, 2008) - "The end of Psoriasis?"

GP Symposium Dermatology Dr Seow Hoong Foo Dr Shireen Velangi March 6th 2014

Efficacy and Safety of Calcipotriol Ointment in Psoriasis Vulgaris - Experiences in Hong Kong

BOWEN S DISEASE (SQUAMOUS CELL CARCINOMA IN SITU)

Arthritis

X-Plain Rheumatoid Arthritis Reference Summary

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES `I. Requirements for Prior Authorization of Cytokine and CAM Antagonists

Acne (Acne Vulgaris) A common type of bacteria that lives on the skin, known as Propionibacterium acnes, sometimes

Information on Rheumatoid Arthritis

The Integumentary System Dr. Ali Ebneshahidi

ACUTE MYELOID LEUKEMIA (AML),

Common Skin Conditions in Children. Liz Moore and Emma King Dermatology Nurse Consultants

1

Case Scenarios. Case Scenario 1 Group A

The Most Common Autoimmune Disease: Rheumatoid Arthritis. Bonita S. Libman, M.D.

Infl ectra for rheumatoid arthritis

Cutaneous Lymphoma FAST FACTS

Bile Duct Diseases and Problems

Guidelines of care for the management of psoriasis and psoriatic arthritis

ENTITLEMENT ELIGIBILITY GUIDELINES PSORIASIS

Understanding Rheumatoid Arthritis

A patient guide to psoriasis/ psoriatic arthritis URAC. All Walgreens specialty pharmacy locations are ACHC and URAC accredited.

Multiple Myeloma. This reference summary will help you understand multiple myeloma and its treatment options.

BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader. Two years ago, I was working as a bedside nurse. One of my colleagues felt

Objectives: Immunity Gone Wrong: Autoimmune Diseases in Dental Hygiene Practice

Muscular Dystrophy and Multiple Sclerosis. ultimately lead to the crippling of the muscular system, there are many differences between these

biologics for the treatment of psoriasis

Psoriasis Field Tests

Transcription:

Running head: PSORIASIS Psoriasis Student's Name Institution Date of Submission

PSORIASIS 1 Abstract Psoriasis is a non-contagious chronic skin disease that is characterized by inflammatory and multiplying itchy patches on the skin and is clinically identified by well established, erythematous red papules and plaques having silvery scales. These patches usually appear on the elbows, knees, external surfaces, and scalp, but may be manifested all over the body (Oguejiofo, 2010). As the condition advances, one may also develop inflamed and achy joints, experience alterations in the appearance of nails, feel fatigue, and develop redness and pain around the eyes. The disease may be influenced by particular systemic and ecological features, but the course cannot be exactly identified. Immune system malfunctions arise from genetic information, where a patient carries genes, such as the tumor necrosis factor (TNF) that is known to cause swellings, highly found in individuals with psoriatic arthritis, and claimed to be one of the instigators (Langley, 2010). The immune malfunction leads to a rapid growth cycle of skin cells, which then die, but instead of falling off accumulate to form patches or, in some cases, inflammations and damages to the joints (Oguejiofo, 2010).

PSORIASIS 2 Genetic Background Psoriasis Disease Process Psoriasis can be caused by a genetic inheritance, though the process of inheritance is unclear, but assumed to be polygenic after analysis of the historical lineage of the patients. HLA system includes genes HLA B16, Cw6, B13, and B27, which are the genetic indicators in different psoriatic populations (Bandyopadhyay, 2012). Provoking Factors Some of the factors that may aggravate and onset psoriasis according to Bandyopadhyay (2012) include: Trauma; this involves the growth of psoriatic wounds at the injured spot, which can be a result of physical, chemical, surgical, infective injuries, or inflammations. This is also known as Koebner phenomenon. Infection; a severe development of guttate psoriasis may occasionally be activated by the infection of streptococcal pharyngitis. Equally, HIV infection is also linked to the intensification in disease. Drugs; exposure to Lithium, withdrawal from systemic corticosteroids, antimalarial drugs, NSAID, and beta-blockers may catalyze the development of the disease (Bandyopadhyay, 2012). Other potential activators of the disease include strong sunlight, psychological stress, cigarette smoking, and alcohol (commonly experienced by males). Role of Immune Response The precise immune-pathogenesis of psoriasis is not clearly known. However, its etiology is associated with immunologic factors. The disease entails development of epidermal

PSORIASIS 3 hyperplasia, existence of acute inflammatory cells, and alterations of vascular inflammation. The skin epidermis and dermis of a psoriatic plaque usually contain high numbers of different immune system cells, such as activated T cells, activated antigen-presenting cells (APCs) (Bandyopadhyay, 2012) (which include Langerhans, dendritic cells, and macrophages), hyperproliferating keratinocytes, and neutrophils (Bandyopadhyay, 2012). The stimulation of the dermal cells, APCs, or keratinocytes may lead to stimulation of antigen production. The secretion of cytokine, lymphokine antigens, and the enhancement of T-cell in turn activates inflammations and hyper-proliferation of epidermal cells bringing to the clinical lesions termed as psoriasis (Bandyopadhyay, 2012). Nursing Assessment Nursing assessment involves physical examination, where a nurse interviews patients about their feelings, possibility of past injury, or exposure to chemicals. A patient suffering from psoriasis may record a feeling of soreness, burning, itchiness of the skin, or painful joints (Langley, 2010). Assessment process also includes inspection, where nurse observes the affected body parts and examines the presence of thickened skin with red papules covered with silvery scales. Palpation helps nurses to identify the texture of thickened skin. Physical examination of a typical lesion of psoriasis manifests features, such as lesions showing distinct borders, which are raised above the skin surface, appear red in color, and may be bounded by a pale halo. The lesions commonly are more than one centimeter in diameter and appear round or oval shaped (Langley, 2010). These lesions sometimes merge to form wide geographic patterns and are enclosed with loosely attached silvery white scales, which, when removed, may expose bleeding points. The parts usually affected are the elbows, shins, sacral regions, nails, and knees, among others. Other than the site variations, there are

PSORIASIS 4 usually morphological variations of the lesions referred to as verrucous, lichenoid, linear, annular, follicular, figurate, and gyrate lesions (Lui, 2012: Oguejiofo, 2010). Implications for Nursing Psoriasis affects skin appearance and, as the skin is an exposed visible organ, can cause extreme psychological responses on patient. Nurses, therefore, have a continuous duty to psychologically help patients suffering from such conditions. This is because the condition affects the person s sense of self-concept. The constituents of self-concept that are normally evaluated by nurses comprise body image and self-esteem. The implications of nursing assessment include patient s psychosocial responses to these components that often result in social isolation and, subsequently, loneliness (Menter & Stoff, 2011). Many individuals in such conditions are usually disturbed by the body image and appearance, fear the risk of social isolation and experience changes in the self-esteem. Nurses need to be aware of the identifying characteristics of this diagnosis and the suitable nursing interventions to be employed that can result in positive patient outcomes (Menter & Stoff, 2011). Nurses are, therefore, in a unique position to handle the multidimensional impacts of psoriasis. Some of the interventions that can be employed are: Promoting understanding of the patient through explanations that there is no cure for psoriasis, though the disease can be controlled through lifetime management and advising patients to avoid the provoking factors. Promoting skin integrity; this is done by advising patients not to scratch psoriatic areas, instead to prevent the skin from drying out and clean with not too hot water, and teaching patients to use bath oil or emollient cleansing agent meant for sore and scaling skin.

PSORIASIS 5 Improving self-concept and body image; this involves introduction of coping strategies that helps minimize stress and training patient to embrace self-care. Treatment Long term treatment is one of the nursing implications that must be initiated after nursing assessment and diagnosis of the psoriasis condition. Psoriasis is a chronic disease and, therefore, its therapy is long-term, needs to be individualized, depending on age, occupation, sex, and severity of the disease and available resources (Menter & Stoff, 2011). Treatment of scalp psoriasis is still a challenge to the dermatologists. An effective management mechanism is essential and should include examination of the severity of the condition. The objectives of management are to slow the possible quick turnover of epidermis and to encourage solutions of the psoriatic lesions by addressing the aggravating factors, assessing the patient s condition with a view of minimizing stress, gentle removal of scales using oils that soften the scales (Lui, 2012). There are three main types of therapy used in handling psoriasis. These include: topical, phototherapy, and systemic agents that can be used independently or concurrently (Bandyopadhyay, 2012). Topical Therapy this is an outpatient therapy used as the basic methodology in the treating mild plaque psoriasis. This involves administration of medicines in cream or ointment forms applied to the affected skin and scalp areas. Phototherapy - used when there is extensive and widespread resistance to topical treatment. This type of therapy requires special facilities that can offer two main forms of phototherapy. The first one is ultraviolet B (UVB) that uses ultraviolet radiation with wavelengths 290-320 nm, and the second is photo chemotherapy (PUVA), which includes a

PSORIASIS 6 photosensitizing drug methoxsalen administered orally to patients, then ultraviolet A (UVA) irradiation to treat individuals with widespread disease (Bandyopadhyay, 2012). Systemic Therapy; this is employed when both, phototherapy and topical forms of treatments prove to be ineffective, and is administered on patients suffering from erythrodermic psoriasis, active psoriatic arthritis, and widespread pustular psoriasis. The major implication that comes with the diagnosis and the treatment of psoriasis is the high cost of this therapy that many patients may not afford. Some of the drugs used in the therapy may include antimetabolites, such as methotrexate, acitretin, cyclosporine, which is used to selectively inhibit the T-helper cell from producing IL-2, thus produces immunosuppressive effects. Others include sulphasalazine and mycophenolate mofetil, which is still under evaluation, intended to prevent synthesis of the nucleotide guanosine (Bandyopadhyay, 2012). Conclusion Psoriasis is a non-contagious chronic skin disease that is manifested by inflammatory itchy patches on the skin and is clinically identified by well established, reddish papules and plaques enclosed with silvery scales that are generally circular or oval shaped. These patches usually appear on the elbows, knees, and on the exterior surfaces and scalp, but may be manifested all over the body. This condition is caused by malfunctions of the immune system and exposure to environmental factors (Langley, 2010). Nursing assessment of the disease is through clinical observation and physical examination for the identifying characteristics of this diagnosis that include feelings related to soreness, burning, itchiness of the skin, or painful joints and presence of lesions that show distinct border, are raised above the skin surface, and appear red in color. There are a lot of nursing implications that range from self-esteem and feeling of isolation to the cost of therapy administration (Menter & Stoff, 2011). The nurses also have a

PSORIASIS 7 responsibility to advice the patients on the best self-practices alongside administration of therapies, such as topical, phototherapy, and systemic agents to maintain the disease.

PSORIASIS 8 References Bandyopadhyay, D. (2012). Psoriasis, Dermatology Lecture Notes, Dept. of Dermatology R. G. Kar Medical College & Hospitals Calcutta India, Retrieved from http://dermind.tripod.com/psoriasis.htm on February 27, 2012 Langley, R. G. (2010). Psoriasis (2nd ed.). Toronto: Key Porter Books. Lui, H. (2012). Psoriasis. Retrieved from http://www.emedicinehealth.com/psoriasis/article_em.htm on February 27, 2012 Menter, A., & B. Stoff (2011). Psoriasis. London: Manson Pub. Oguejiofo, N. (2010). Psoriasis & Nursing Assessments. Retrieved from http://www.livestrong.com/article/227308-psoriasis-nursing-assessments/ on February 27, 2012